Mutual Advisors LLC Has $1.85 Million Stock Position in Danaher Corporation $DHR

Mutual Advisors LLC lowered its holdings in Danaher Corporation (NYSE:DHR) by 4.3% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,004 shares of the conglomerate’s stock after selling 405 shares during the quarter. Mutual Advisors LLC’s holdings in Danaher were worth $1,850,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. GAMMA Investing LLC grew its holdings in Danaher by 22.2% in the 1st quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate’s stock valued at $1,871,000 after buying an additional 1,660 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in Danaher by 4.0% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 207,169 shares of the conglomerate’s stock valued at $42,470,000 after buying an additional 7,907 shares during the last quarter. Kingswood Wealth Advisors LLC grew its holdings in Danaher by 1.6% in the 1st quarter. Kingswood Wealth Advisors LLC now owns 3,466 shares of the conglomerate’s stock valued at $710,000 after buying an additional 56 shares during the last quarter. Dunhill Financial LLC grew its holdings in Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after buying an additional 67 shares during the last quarter. Finally, CWA Asset Management Group LLC grew its holdings in Danaher by 8.6% in the 1st quarter. CWA Asset Management Group LLC now owns 3,317 shares of the conglomerate’s stock valued at $680,000 after buying an additional 263 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

Danaher stock opened at $210.86 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The company has a market capitalization of $150.99 billion, a PE ratio of 44.86, a price-to-earnings-growth ratio of 2.94 and a beta of 0.77. Danaher Corporation has a one year low of $171.00 and a one year high of $279.41. The business has a 50 day simple moving average of $201.43 and a 200 day simple moving average of $197.23.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.Danaher’s revenue was up 3.4% on a year-over-year basis. During the same quarter last year, the company earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 27.23%.

Wall Street Analyst Weigh In

DHR has been the topic of several recent research reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a report on Wednesday, October 8th. Guggenheim reissued a “buy” rating and set a $250.00 price objective on shares of Danaher in a report on Wednesday, July 23rd. Rothschild & Co Redburn reissued a “neutral” rating and set a $220.00 price objective (down previously from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Scotiabank raised Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective on the stock in a report on Friday, July 11th. Finally, Barclays reissued an “overweight” rating and set a $225.00 price objective (up previously from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Seventeen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $244.60.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 11.10% of the stock is owned by company insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.